A Study of Minirin Melt in Patients With Nocturia

Completed

• Conditions: Nocturia

• Registration Number: NCT01212224
• Lead Sponsor: Ferring Pharmaceuticals

Brief Summary

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-01
• Study First Submitted: 2010-09-21
• Study First Submitted QC: 2010-09-29
• Study First Posted: 2010-09-30
• Primary Completion: 2013-03
• Study Completion: 2013-12
• Status Verified: 2014-01
• Last Update Submitted: 2014-01-03
• Last Update Posted: 2014-01-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2187

Inclusion Criteria

• nocturia

Exclusion Criteria

• habitual or psychogenic polydipsia
• known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics
• moderate and severe renal insufficiency
• know hyponatremia
• syndrome of inappropriate ADH secretion

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Verify the safety profile	12 months

Secondary Outcome Measures

Name	Time	Method
Safety aspect of dosage	12 months

Trial Locations

Locations (68)

Nemocnice Rudolfa a Stefanie; 🇨🇿 Benešov, Czech Republic

Private ambulance Benešov; 🇨🇿 Benešov, Czech Republic

Private ambulance Beroun; 🇨🇿 Beroun, Czech Republic

Private ambulance - Slezská urologie, s.r.o.; 🇨🇿 Bohumín, Czech Republic

Private ambulance; 🇨🇿 Šumperk, Czech Republic

Health centre Brno; 🇨🇿 Brno, Czech Republic

Hospital Accident; 🇨🇿 Brno, Czech Republic

Hospital Delta - private ambulance; 🇨🇿 Brno, Czech Republic

Private ambulance Uro-Clinic, s.r.o.; 🇨🇿 Brno, Czech Republic

Urocentrum; 🇨🇿 Brno, Czech Republic

Scroll for more (58 remaining)